Related references
Note: Only part of the references are listed.Highly purified human peripheral blood monocytes produce IL-6 but not TNFα in response to angiotensin II
Laura Gelinas et al.
JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM (2011)
The T helper type 17/regulatory T cell imbalance in patients with acute Kawasaki disease
S. Jia et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2010)
IL-6: Regulator of Treg/Th17 balance
Akihiro Kimura et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2010)
Monocyte-mediated defense against microbial pathogens
Natalya V. Serbina et al.
ANNUAL REVIEW OF IMMUNOLOGY (2008)
Resistance to intravenous immunoglobulin in children with Kawasaki disease
Adriana H. Tremoulet et al.
JOURNAL OF PEDIATRICS (2008)
Polymorphisms in chemokine receptor genes and susceptibility to Kawasaki disease
W. B. Breunis et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2007)
Lymphocyte recruitment into the aortic wall before and during development of atherosclerosis is partially L-selectin dependent
Elena Galkina et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Heart disease and stroke statistics - 2006 update - A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee
T Thom et al.
CIRCULATION (2006)
Monocyte and macrophage heterogeneity
S Gordon et al.
NATURE REVIEWS IMMUNOLOGY (2005)
Kawasaki disease - Infection, immunity and genetics
CL Wang et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2005)
Immunological profile of peripheral blood lymphocytes and monocytes/macrophages in Kawasaki disease
T Matsubara et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2005)
CD25+ CD4+ regulatory T cells in patients with Kawasaki disease
K Furuno et al.
JOURNAL OF PEDIATRICS (2004)
High concentrations of interleukin-8 and monocyte chemoattractant protein-1 in urine of patients with acute Kawasaki disease
T Jibiki et al.
EUROPEAN JOURNAL OF PEDIATRICS (2004)
Induction of coronary arteritis with administration of CAWS (Candida albicans water-soluble fraction) depending on mouse strains
N Nagi-Miura et al.
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY (2004)
Propagermanium suppresses macrophage-mediated formation of coronary arteriosclerotic lesions in pigs in vivo
H Shimokawa et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2003)
Long-term, treatment with propagermanium suppresses atherosclerosis in WHHL rabbits
Y Eto et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2003)
Circulating interleukin 17 is increased in the acute stage of Kawasaki disease
MH Sohn et al.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2003)
Propagermanium reduces atherosclerosis in apolipoprotein E knockout mice via inhibition of macrophage infiltration
T Yamashita et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2002)
Surface and cytoplasmic immunoglobulin expression in circulating B-lymphocytes in acute Kawasaki disease
D Shingadia et al.
PEDIATRIC RESEARCH (2001)
An anti-inflammatory drug, propagermanium, may target GPI-anchored proteins associated with an MCP-1 receptor, CCR2
S Yokochi et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2001)
CD14(+)CD16(+) monocyte subpopulation in Kawasaki disease
K Katayama et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2000)
Share Paper
